Author: Nicholas Alan Clayton

AMCI II (AMCI) Adds $50M PIPE to LanzaTech Deal

AMCI II (NASDAQ:AMCI) announced this morning that it has added a $50 million PIPE to its combination with renewable materials-maker LanzaTech.

Woodside Energy (ASX:WDS) is investing in this PIPE at $10 per share and the two sides expect a strategic collaboration to follow, accelerating LanzaTech’s scale-up as it seeks out new ways to capture carbon and turn it into new industrial feedstocks.

...READ MORE

Tastemaker Acquisition Corp. (TMKR) to Combine with Quality Gold in $989M Deal

Tastemaker (NASDAQ:TMKR) has entered into a definitive agreement to combine with jewelry distributor Quality Gold at an enterprise value of $989 million, or 12x its 2022 adjusted EBITDA. The Fairfield, Ohio-based company sells about 165,000 jewelry SKUs through 15,000 retailers and its native ecommerce site with vertically integrated production, wholesaling and sales operations. The combined
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Mountain Crest V (MCAG) to Combine with AUM Biosciences in $400M Deal

Mountain Crest V (NASDAQ:MCAG) has entered into a definitive agreement to combine with biotech firm AUM Biosciences at an equity value of $400 million. Singapore-based AUM is working to develop a range of drugs that could improve the effectiveness of cancer treatments with its most advanced candidates entering Phase II. The combined company is expected
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
super apps

Evo Acquisition Corp. (EVOJ) to Combine with 20Cube Logistics in $338M Deal

Evo Acquisition Corp. (NASDAQ:EVOJ) has entered into a definitive agreement to combine with logistics technology firm 20Cube at an enterprise value of $338 million, or 26.2x its 2022E adjusted EBITDA. Singapore-based 20Cube provides an end-to-end logistics software platform to deliver products from vendors to buyers along the supply chain primarily in major Asian markets. The
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Parsec Capital Acquisitions Corp. (PCX) to Combine with Enteractive Media

Parsec Capital (NASDAQ:PCX) has entered into a definitive agreement to combine with Enteractive Media. Toronto-based Enteractive provides media content and streams covering gambling events and esports with other services designed at providing gambling tips. Transaction Overview Parsec Capital currently has an estimated $88 million in its pre-redemptions trust and it is to issue 5,000,000 shares
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
Archaea logo

European Biotech Acquisition Corp (EBAC) to Combine with Oculis SA in $218M Deal

European Biotech (NASDAQ:EBAC) has entered into a definitive agreement to combine with biopharmaceutical firm Oculis at an enterprise value of $218 million. Lausanne, Switzerland-based Oculis is developing a range of therapies for eye diseases with the most advanced having entered Phase III trials. The combined company is expected to trade on the Nasdaq once the
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

HH&L Acquisition Corp. (HHLA) to Combine with DiaCarta in $460M Deal

HH&L (NYSE:HHLA) has entered into a definitive agreement to combine with biotech firm DiaCarta at a pre-money equity value of $460 million. Pleasanton, California-based DiaCarta produces a range of viral and DNA tests to detect ailments early or perform tasks in conjunction with treatment. The combined company is expected to trade on the NYSE once
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
Haymaker OneSpaWorld

Good Works II (GWII) to Combine with Direct Biologics in $723M Deal

Good Works II (NASDAQ:GWII) has entered into a definitive agreement to combine with drug developer Direct Biologics at an enterprise value of $723 million. Austin, Texas-based Direct Biologics is developing anti-inflammatory treatments aimed at accelerating recovery from COVID-19 infection and other respiratory and inflammation-related ailments. The combined company is expected to trade on the Nasdaq
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Clean Earth Acquisitions Corp. (CLIN) to Combine with Alternus Energy in $992M Deal

Clean Earth (NASDAQ:CLIN) has entered into a definitive agreement to combine with climate technology company Alternus (OSE:ALT) at an enterprise value of $992 million, or 21x its 2023E EBITDA. Dublin, Ireland-based Alternus installs, owns and operates midsized utility scale solar plants and plans to have about 3.5 GW of generation assets in this portfolio by
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Horizon Acquisition Corporation II (HZON) to Combine with Flexjet in $3.1Bn Deal

Horizon II (NYSE:HZON) has entered into a definitive agreement to combine with private aviation company Flexjet at an enterprise value of $3.1 billion, or about 1.3x its 2022E revenue. Richmond Heights, Ohio-based Flexjet operates a membership-based travel network for private plane transportation. The combined company is expected to trade on the NYSE under the symbol
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
digitial world dwac-tmtg logo